Science Explorer Back to mapMap
Discussion
Researcher · Newron Pharmaceuticals (Italy) · Italy

Giovanni Chinellato

Giovanni Chinellato publishes mostly in Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience, on topics such as Treatment of Major Depression, Schizophrenia research and treatment and Neuroscience and Neuropharmacology Research.

ORCID 0009-0001-7091-8672 OpenAlex
World rank
#5,920,434
of 7,710,434 ranked researchers
Rank in Italy
#196,818
of 242,206
Works
20
Citations
47
Citations per work
2.4
h-index
3
i10-index 2Top 97% in Psychiatry and Mental health
Giovanni Chinellato

What does Giovanni Chinellato research?

Giovanni Chinellato's work is mostly in Medicine (55%), Neuroscience (17%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 11 works · 55.3% of their workMedicine: 11 works · 55.3% of their workPsychiatry and Mental health: 5 works · 25.5% of their workPharmacology: 4 works · 19.1% of their workPhysiology: 1 works · 6.4% of their workInfectious Diseases: 1 works · 4.3% of their workLife Sciences: 5 works · 23.4% of their workNeuroscience: 3 works · 17.0% of their workCellular and Molecular Neuroscience: 3 works · 17.0% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 6.4% of their workMolecular Biology: 1 works · 6.4% of their workEverything else: 4 works · 21.3% of their workTHEIR WORKGiovanniChinellato20works
Life Sciences23%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1155.3%
    1. Neuroscience317.0%
    2. Biochemistry, Genetics and Molecular Biology16.4%
  3. Everything else421.3%
  1. 1Psychiatry and Mental health26% of their works
  2. 2Pharmacology19% of their works
  3. 3Cellular and Molecular Neuroscience17% of their works
  4. 4Physiology6% of their works
  5. 5Molecular Biology6% of their works
  6. 6Infectious Diseases4% of their works

Research topics

Which keywords describe Giovanni Chinellato's research?

The keywords of their largest research topics: Synaptic Plasticity, Metabolic Syndrome, Depression, Neurological Disorders, Antidepressant, Antipsychotic Drugs, Ketamine and Neurocognitive Deficits.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Synaptic Plasticity162 topics
  2. Metabolic Syndrome122 topics
  3. Depression112 topics
  4. Neurological Disorders102 topics
  5. Antidepressant91 topic
  6. Antipsychotic Drugs91 topic
  7. Ketamine91 topic
  8. Neurocognitive Deficits91 topic
  9. GABAergic71 topic
  10. Neurotransmission71 topic
  11. Inflammation52 topics
  12. Ketogenic Diet31 topic
  13. Low-Carbohydrate Diet31 topic
  14. Bipolar Spectrum Disorder21 topic
  15. Crystal Structure21 topic
  16. Emotion Regulation21 topic
  17. G-Protein-Coupled Receptors21 topic
  18. Prevalence21 topic
  19. Psychopathology21 topic
  20. Cyclic Nucleotide Phosphodiesterases11 topic
  21. cAMP Signaling11 topic

Where does Giovanni Chinellato work?

Giovanni Chinellato's main affiliation in the publication record is Newron Pharmaceuticals (Italy), Italy.

How many publications and citations does Giovanni Chinellato have?

OpenAlex counts 20 works and 47 citations for Giovanni Chinellato, an h-index of 3, ranking #5,920,434 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Giovanni Chinellato. Posts are plain text and can be reported.